Aerami Therapeutics today announced positive data supporting its inhaled imatinib for treating pulmonary hypertension (PH). Studies of AER-901 support progression into a Phase 2 clinical trial. Data backed Aerami's treatment for both PH associated … [Read More...] about Aerami presents positive data for inhaled pulmonary hypertension treatment
Main Content
Sponsored Content
Patient Training is Broken – And Everyone is Paying For It
Noble International is working with Pharma and Specialty Pharmacy to fix the problem. The report, “The Current Paradigm for Biologic Initiation: A Mixed-Methods Exploration of Practices, Unmet … [Read More...] about Patient Training is Broken – And Everyone is Paying For It
Featured Posts
Analysts still high on Insulet despite Medtronic’s EOFlow buy, stock market reaction
Despite a negative reaction from investors following a major buy in the insulin delivery space, analysts still back Insulet (Nasdaq:PODD) stock to perform. Shares of PODD fell throughout today after Medtronic (NYSE:MDT) announced a $738 million … [Read More...] about Analysts still high on Insulet despite Medtronic’s EOFlow buy, stock market reaction
Convatec, Beta Bionics partner on iLet bionic pancreas
Convatec announced that it partnered with Beta Bionics on the launch of the iLet Bionic Pancreas for automated insulin delivery. FDA last week cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software. Convatec … [Read More...] about Convatec, Beta Bionics partner on iLet bionic pancreas
Medtronic to acquire wearable insulin patch maker EOFlow for $738M
Medtronic (NYSE:MDT) announced today that it entered into a set of agreements to acquire insulin delivery technology developer EOFlow. Seongnam, South Korea-based EOFlow develops the EOPatch — a tubeless, wearable and fully disposable insulin … [Read More...] about Medtronic to acquire wearable insulin patch maker EOFlow for $738M
ClearPoint Neuro enters drug delivery licensing deal with UCB
ClearPoint Neuro (Nasdaq:CLPT) announced today that it entered into a multi-year license agreement with UCB over gene therapy delivery. Solana Beach, California-based ClearPoint Neuro develops a therapy-enabling platform providing navigation and … [Read More...] about ClearPoint Neuro enters drug delivery licensing deal with UCB
Aerami presents positive data for inhaled pulmonary hypertension treatment
Aerami Therapeutics today announced positive data supporting its inhaled imatinib for treating pulmonary hypertension (PH). Studies of AER-901 support progression into a Phase 2 clinical trial. Data backed Aerami's treatment for both PH associated … [Read More...] about Aerami presents positive data for inhaled pulmonary hypertension treatment
ICU Medical recalls certain infusion pump replacement batteries
The FDA issued a notice determining that the recall of ICU Medical (Nasdaq:ICUI) infusion pump batteries is Class I, the most serious kind. ICU Medical initiated a recall of replacement batteries for certain infusion systems on March 22, 2023. The … [Read More...] about ICU Medical recalls certain infusion pump replacement batteries
FDA approves another nasal spray for treating opioid overdose
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant Pharmaceuticals. Approval covers the treatment of known or suspected opioid overdose in adults and pediatric patients 12 years … [Read More...] about FDA approves another nasal spray for treating opioid overdose
BD expands availability of all-in-one flush pre-filled syringe
BD (NYSE:BDX) announced today that it expanded customer availability for its all-in-one pre-filled flush syringe. Franklin Lakes, New Jersey-based BD designed its PosiFlush SafeScrub syringe with an integrated disinfection unit. It reinforces … [Read More...] about BD expands availability of all-in-one flush pre-filled syringe
FDA clears automated insulin pump from Beta Bionics for type 1 diabetes
The FDA announced today that it cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software. FDA clearance covers the devices for people 6 years of age and older with type 1 diabetes. Combined with a compatible, … [Read More...] about FDA clears automated insulin pump from Beta Bionics for type 1 diabetes
Study supports smart blood glucose meter from LifeScan
LifeScan today announced positive data from a study of real-world evidence supporting its Bluetooth-connected blood glucose meter. Evidence from more than 55,000 people with diabetes demonstrated sustained improvements in readings in range. The … [Read More...] about Study supports smart blood glucose meter from LifeScan
In case you missed it
- Schott Pharma launches pre-filled polymer syringes for deep-cold drugs
- DiogenX raises $30M for regenerative diabetes treatment
- Dexcom touts more clinical evidence for G6 CGM in Japan
- Embecta stock rises on Q2 results, reports progress on automated insulin delivery tech
- Micron Biomedical raises $17M for needle-free drug delivery tech
- Senseonics stock rises after hours on Street-beating Q1
- Study backs Fitterfly digital therapeutic for diabetes management
- Ascensia expands payment program for Senseonics Eversense E3 CGM
- FDA approves ophthalmic spray from Eyenovia
- Insulet restructures leadership team to drive growth
- Study supports feasibility of Know Labs non-invasive CGM
- Insulet reports 21% sales growth in Q1, raises 2023 guidance
- Tandem stock dips after hours on Q1 misses as it teases 2023 product launches
- Sernova, AstraZeneca collaborate to deliver therapeutic cells with Sernova Cell Pouch
- UK study backs Dexcom real-time CGM
Clinical Trials
Aerami presents positive data for inhaled pulmonary hypertension treatment
Aerami Therapeutics today announced positive data supporting its inhaled imatinib for treating pulmonary hypertension (PH). Studies of AER-901 support progression into a Phase 2 clinical trial. Data backed Aerami’s treatment for both PH associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH). AER-901 is a drug-device combination. Aerami designed it to deliver potentially […]
Study supports smart blood glucose meter from LifeScan
LifeScan today announced positive data from a study of real-world evidence supporting its Bluetooth-connected blood glucose meter. Evidence from more than 55,000 people with diabetes demonstrated sustained improvements in readings in range. The analysis focuses on changes over 180 days. LifeScan published results in the peer-reviewed journal Diabetes Therapy. The company’s OneTouch Bluetooth-connected blood glucose […]
Dexcom touts more clinical evidence for G6 CGM in Japan
Dexcom (Nasdaq:DXCM) announced that it showcased its Dexcom G6 CGM at the 66th Annual Meeting of the Japan Diabetes Society. G6, now the previous-generation version of the company’s CGM after the launch of the G7, uses a small, wearable sensor. It also features a transmitter, continuously measuring and sending glucose levels wirelessly to a smart […]
Study backs Fitterfly digital therapeutic for diabetes management
New research published in JMIR Diabetes demonstrated the real-world effectiveness of the Fitterfly Diabetes digital therapeutic program. The Fitterfly Diabetes CGM digital therapeutic aims to help in the management of glycemic control for people with type 2 diabetes. Led by Shilpa Joshi, Arbinder Singal, and colleagues, the study demonstrated significant improvements in blood glucose levels and […]
Researchers use skull-implantable ultrasound to help deliver chemotherapy to the brain
Northwestern Medicine shared results from a first-in-human clinical trial for a skull-implantable ultrasound device that supports chemotherapy delivery. The device opened the blood-brain barrier to repeatedly permeate large, critical regions of the human brain. This enabled the delivery of chemotherapy injected intravenously. With the patient awake, a four-minute procedure opens the blood-brain barrier and patients […]
